American Society of Clinical Oncology (ASCO) Breakthrough (ASCOBT22)



ASCO Breakthrough, A Global Summit for Oncology Innovators, cohosted by the Japan Society of Clinical Oncology (JSCO) and the Japanese Society of Medical Oncology (JSMO), will bring together leaders in oncology medicine, research and technology to explore cutting-edge science and technology that is transforming cancer care with remarkable new therapies. ASCO Breakthrough will offer highly interactive scientific sessions on the most innovative subjects in oncology – artificial intelligence (AI), new diagnostics, delivery of care.

On the agenda:

  • Protein Degradation as a Therapeutic Strategy
  • The Impact of COVID-19 on Oncology Practice: New Challenges and Solutions
  • Disease Focused: Case-Based Applications Session
  • How Science, Technology, and Practice Can be Enabled in Low and Middle Resource Settings
  • Artificial Intelligence in Software for Breast Cancer Diagnosis
  • Targeting the T-Cell Receptor
  • New Generation of Antibody Drug Conjugates for Cancer Treatment
  • Are Personalized Cancer Vaccines Ready for the Clinic?
  • The Truth and Myth of Stem Cell Therapy
  • Cancer and Big Data
  • AI Drug Design and Development
  • Impact of Microbiome on Colon Cancer
  • Impact of Microbiome on Tumor Growth
  • Organoids Technology
  • Liquid Biospy
  • Single Cell Sequencing
  • The Art and Science of Telemedicine
Possible contact:

Venue: PACIFICO Yokohama


August 25-27, 2022


Yokohama, Japan